1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LEGEND BIOTECH CORP - ADR
Legend Biotech Corp - ADR XNAS: LEGN

Legend Biotech Corp - ADR Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen rece...

Read More
39.07 -1.34 (-3.32%)
34.47% Fall from 52W High
1.4M
XNAS Volume

XNAS 31 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Legend Biotech Corp - ADR is on 11 Aug 2025 for the purpose of Legend Biotech Corp Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
9.7 / 100
Momentum Score
Technically Neutral
51.9 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
76
1Yr Price target upside is 95%
19 analysts

12

S

12

W

3

O

2

T

SWOT Analysis

Legend Biotech Corp - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..